Reported Standalone quarterly numbers for Indo US Bio-Tech are:
Net Sales at Rs 30.85 crore in September 2025 up 39.12% from Rs. 22.17 crore in September 2024.
Story continues below Advertisement
Quarterly Net Profit at Rs. 3.45 crore in September 2025 down 20.81% from Rs. 4.36 crore in September 2024.
EBITDA stands at Rs. 4.19 crore in September 2025 down 18.48% from Rs. 5.14 crore in September 2024.
Indo US Bio-Tec EPS has decreased to Rs. 1.72 in September 2025 from Rs. 2.16 in September 2024.
Story continues below Advertisement
Indo US Bio-Tec shares closed at 124.01 on November 17, 2025 (NSE) and has given -17.80% returns over the last 6 months and -50.41% over the last 12 months.
| Indo US Bio-Tech | | Standalone Quarterly Results | in Rs. Cr. |
|
| Sep'25 | Jun'25 | Sep'24 | | Net Sales/Income from operations | 30.85 | 30.77 | 22.17 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 30.85 | 30.77 | 22.17 | | EXPENDITURE | | Consumption of Raw Materials | 28.34 | -- | 11.14 | | Purchase of Traded Goods | 0.60 | 7.15 | 0.09 | | Increase/Decrease in Stocks | 3.66 | 6.13 | 3.30 | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.34 | 0.32 | 0.24 | | Depreciation | 0.21 | 0.20 | 0.18 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | -6.24 | 11.70 | 2.28 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 3.96 | 5.27 | 4.95 | | Other Income | 0.03 | 0.00 | 0.02 | | P/L Before Int., Excpt. Items & Tax | 3.98 | 5.27 | 4.96 | | Interest | 0.42 | 0.45 | 0.52 | | P/L Before Exceptional Items & Tax | 3.56 | 4.82 | 4.45 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 3.56 | 4.82 | 4.45 | | Tax | 0.11 | 0.12 | 0.09 | | P/L After Tax from Ordinary Activities | 3.45 | 4.70 | 4.36 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 3.45 | 4.70 | 4.36 | | Equity Share Capital | 20.05 | 20.05 | 20.05 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 1.72 | 2.35 | 2.16 | | Diluted EPS | -- | 2.35 | 2.16 | | EPS After Extra Ordinary | | Basic EPS | 1.72 | 2.35 | 2.16 | | Diluted EPS | -- | 2.35 | 2.16 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
